Application of Multiplex Nested Methylated Specific PCR in Early Diagnosis of Epithelial Ovarian Cancer |
Wang, Bi
(Guiyang Medical University)
Yu, Lei (The First School of Medicine, The First Affiliated Hospital of Jinan University) Yang, Guo-Zhen (Guiyang Medical University) Luo, Xin (Department of Obstetrics and Gynecology, The First Affiliated Hospital of Jinan University) Huang, Lin (Department of Obstetrics and Gynecology, Affiliated Hospital of Guiyang Medical University) |
1 | Amornpisutt R, Proungvitaya S, Jearanaikoon P, et al (2015). DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma. Tumour Biol, (in press). |
2 | Buys SS, Partridge E, Black A, et al (2011). Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial. JAMA, 305, 2295-303. DOI |
3 | Clarke-Pearson DL (2009). Screening for ovarian cancer. New Engl J Med, 361, 170-7. DOI |
4 | Chen H, Zhang C, Sheng Y, et al (2014). Frequent SOCS3 and 3OST2 promoter methylation and their epigenetic regulation in endometrial carcinoma. Am J Cancer Res, 5, 180-90. |
5 | Guo S, Yan F, Xu J, et al (2015). Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC). Clin Epigenetics, 7, 3. DOI |
6 | Ji T, Zheng ZG, Wang FM, et al (2014). Differential microRNA expression by Solexa sequencing in the sera of ovarian cancer patients. Asian Pac J Cancer Prev, 15, 1739-43. DOI ScienceOn |
7 | Karami S, Andreotti G, Liao LM, et al (2015). LINE-1 methylation levels in pre-diagnostic leukocyte DNA and future renal cell carcinoma risk. Epigenetics, (in press). |
8 | Liggett TE, Melnikov A, Yi Q, et al (2011). Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors. Gynecol Oncol, 120, 113-20. DOI |
9 | McIntosh MW, Liu Y, Drescher C, et al (2007). Validation and characterization of human kallikrein 11 as a serum marker for diagnosis of ovarian carcinoma. Clin Cancer Res, 13, 4422-8. DOI |
10 | Nelissen EC, van Montfoort AP, Dumoulin JC, et al (2011). Epigenetics and the placenta. Hum Reprod Update, 17, 397-417. DOI ScienceOn |
11 | Nordlund J, Bäcklin CL, Zachariadis V, et al (2015). DNA methylation-based subtype prediction for pediatric acute lymphoblastic leukemia. Clin Epigenetics, 7, 11. DOI |
12 | Pothuri B, Leitao MM, Levine DA, et al (2010). Genetic analysis of the early natural history of epithelial ovarian carcinoma. PLoS One, 5, 10358. DOI |
13 | Shih IeM, Kurman RJ (2004). Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol, 164, 1511-8. DOI |
14 | Siegel R, Deepa Naishadham MA, Ahmedin Jemal DVM (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30. DOI ScienceOn |
15 | Tost J (2010). DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker. Mol Biotechnol, 44, 71-81. DOI |
16 | Yu Shaorong, Liu Baorui, Lu Jianwei, et al (2013). Circulating DNA as potential biomarker for cancer individualized therapy. J Int Transl Med, 1, 144-51. |
17 | The Department of Health, Australian Government (2011). Cancer facts and figures. http://www.health.gov.au/internet/main/publishing.nsf/Content/cancer-facts |
18 | Tiwawech D, Srisuttee R, Rattanatanyong P, et al (2014). Alu methylation in serum from patients with nasopharyngeal carcinoma. Asian Pac J Cancer Prev, 15, 9797-800. DOI |
19 | Wang B, Liu SZ, Zheng RS, et al (2014).Time trends of ovarian cancer incidence in China. Asian Pac J Cancer Prev, 15, 191-3. DOI ScienceOn |
20 | Yamashita K, Waraya M, Kim MS, et al (2014). Detection of methylated CDO1 in plasma of colorectal cancer; a PCR study. PLoS One, 9, 113546. DOI |
21 | Zhou F, Ma M, Tao G, et al (2014). Detection of circulating methylated opioid binding protein/cell adhesion moleculelike gene as a biomarker for ovarian carcinoma. Clin Lab, 60, 759-65. |
![]() |